China Universal Asset Management Co., Ltd. Cogent Biosciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q2 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 22,868 shares of COGT stock, worth $363,601. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,868
Previous 22,836
0.14%
Holding current value
$363,601
Previous $136,000
20.59%
% of portfolio
0.02%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding COGT
# of Institutions
203Shares Held
118MCall Options Held
2.84MPut Options Held
828K-
Paradigm Biocapital Advisors LP New York, NY10.4MShares$165 Million3.47% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.49MShares$135 Million7.28% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$116 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$111 Million10.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.52MShares$104 Million0.0% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $1.05B
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...